25-Year Trends in Stage-Specific Incidence Rates for Bladder Cancer in a Large Statewide Registry

Author:

Loloi Justin1,Lin Yu-Kuan1,Camacho Fabian2,Lengerich Eugene2,Raman Jay D.1

Affiliation:

1. Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA

2. Department of Public Health Sciences, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA

Abstract

BACKGROUND: Bladder cancer (BC) is a common genitourinary malignancy with over 80,000 new cases diagnosed annually and over 17,000 associated deaths. OBJECTIVE: We review 25-years of BC incidence (1993-2017) within the state of Pennsylvania to better define incidence, geographic distribution, and trends over time. METHODS: The Pennsylvania Cancer Registry was reviewed for statewide and component county age-adjusted BC incidence rates and stage distribution. Chloropleth maps plotting statewide and county-specific incidence rates across time were created using the GeoDa statistical package. RESULTS: 93,476 cases of BC were recorded in Pennsylvania from 1993 to 2017. Age-adjusted annual rates of BC over the study interval were stable at 24.5 patients per 100,000 (range, 22.7–25.6). However, annual rates of distant disease increased from 0.5 to 1.1 patients per 100,000 (p < 0.001) with an average percent change increase of 6.6% over the study interval. The annual percent distribution of distant disease doubled from 2.3% to 5.1% (p < 0.001) with a greater increase in women compared to men. Chloropleth maps highlighted growing “hot spots” of bladder cancer incidence in the northwestern, northeastern, and southeastern portions of the state. CONCLUSIONS: While BC incidence in the state of Pennsylvania has remained relatively stable over the past 25 years, a concerning increase in distant disease was observed. Geospatial investigation implicates higher risk regions. Further studies are necessary to delineate the underlying etiologies for these observations.

Publisher

IOS Press

Subject

Urology,Oncology

Reference19 articles.

1. Understanding urothelial carcinoma through cancer pathways;Schulz;Int J Cancer,2006

2. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

3. Saginala K , Barsouk A , Aluru JS , Rawla P , Padala SA . Epidemiology of Bladder Cancer. Med Sci (Basel). 2020;8(1).

4. Substance Abuse and Mental Health Services A, Office of the Surgeon G. Publications and Reports of the Surgeon General. Smoking Cessation: A Report of the Surgeon General. Washington (DC): US Department of Health and Human Services; 2020.

5. Bladder cancer, a review of the environmental risk factors;Letasiova;Environ Health,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3